More Potential Help for Chronic Hand Eczema

(MedPage Today) -- Two different Janus kinase (JAK) inhibitors, one systemic and the other topical, showed activity in preliminary clinical trials of difficult-to-treat chronic hand eczema.
The oral multitargeted drug gusacitinib reduced the target...